Detalhe da pesquisa
1.
Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancer.
Gynecol Oncol
; 185: 186-193, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38447347
2.
Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer.
Gynecol Oncol
; 170: 241-247, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36736157
3.
Trends in the use of neoadjuvant chemotherapy for low-grade serous ovarian cancer in the United States.
Gynecol Oncol
; 175: 60-65, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37327540
4.
DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinoma.
Gynecol Oncol
; 172: 82-91, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001446
5.
Normal transaminases in obese patients with metabolic associated steatohepatitis (MASH): a cohort of Peruvian patients.
Rev Gastroenterol Peru
; 42(2): 99-105, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36513355
6.
Population exposure-efficacy and exposure-safety analyses for rucaparib in patients with recurrent ovarian carcinoma from Study 10 and ARIEL2.
Gynecol Oncol
; 161(3): 668-675, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33752918
7.
Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer.
Gynecol Oncol
; 157(2): 379-385, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32081463
8.
New Technologies for Analysis of Extracellular Vesicles.
Chem Rev
; 118(4): 1917-1950, 2018 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29384376
9.
Suspension training vs. traditional resistance training: effects on muscle mass, strength and functional performance in older adults.
Eur J Appl Physiol
; 120(10): 2223-2232, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32700098
10.
[Autoimmune hepatitis and pregnancy: a case series]. / Hepatitis autoinmune y embarazo: serie de casos.
Rev Gastroenterol Peru
; 39(3): 292-298, 2019.
Artigo
em Espanhol
| MEDLINE | ID: mdl-31688857
11.
Totally Laparoscopic Radical Resection of Gallbladder Cancer: Technical Aspects and Long-Term Results.
World J Surg
; 42(8): 2592-2598, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29520484
12.
AAV9 delivering a modified human Mullerian inhibiting substance as a gene therapy in patient-derived xenografts of ovarian cancer.
Proc Natl Acad Sci U S A
; 112(32): E4418-27, 2015 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26216943
13.
Digital diffraction analysis enables low-cost molecular diagnostics on a smartphone.
Proc Natl Acad Sci U S A
; 112(18): 5613-8, 2015 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25870273
14.
Facile Coating Strategy to Functionalize Inorganic Nanoparticles for Biosensing.
Bioconjug Chem
; 28(1): 33-37, 2017 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27792877
15.
Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated analysis of data from Study 10 and ARIEL2.
Gynecol Oncol
; 147(2): 267-275, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28882436
16.
Exploring alternative ovarian cancer biomarkers using innovative nanotechnology strategies.
Cancer Metastasis Rev
; 34(1): 75-82, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25543192
17.
Ascites analysis by a microfluidic chip allows tumor-cell profiling.
Proc Natl Acad Sci U S A
; 110(51): E4978-86, 2013 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24297935
18.
Molecular characterization of scant lung tumor cells using iron-oxide nanoparticles and micro-nuclear magnetic resonance.
Nanomedicine
; 10(3): 661-8, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24200523
19.
Prevalence of cervical intraepithelial lesions and associated factors among women attending a cervical cancer clinic in Western Uganda; results based on Pap smear cytology.
SAGE Open Med
; 12: 20503121241252265, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38764539
20.
Combined aromatase, CDK4/6 and PI3K blockade using letrozole/abemaciclib/LY3023414 in endometrial cancer.
Gynecol Oncol Rep
; 52: 101348, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38425459